title: Gastroesophageal junction carcinoma multimodal treatment: standards, debate and new therapeutic options.
authors.forename: Theodore
authors.initials: T
authors.lastname: Liakakos
authors.forename: Christos
authors.initials: C
authors.lastname: Katsios
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism / Q000628:therapy*; D014408:Biomarkers, Tumor / Q000378:metabolism; D003131:Combined Modality Therapy; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000378:metabolism; D004938:Esophageal Neoplasms / Q000378:metabolism / Q000628:therapy*; D004943:Esophagogastric Junction / Q000187:drug effects / Q000528:radiation effects / Q000601:surgery; D006657:Histones / Q000378:metabolism; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000378:metabolism / Q000628:therapy*
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D006657:Histones; D035683:MicroRNAs; D018719:Erb-b2 Receptor Tyrosine Kinases